Innova Captab Limited — Investor Meet, 13-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** Innova Captab reported consolidated revenue of ₹316.5 crore for Q3 FY25, showing a 4.6% year-on-year growth. The Contract Development and Manufacturing Organization (CDMO) segment generated ₹172.2 crore, comprising 54% of total revenue, while domestic sales amounted to ₹58.6 crore (19% of revenue), and international sales reached ₹41.2 crore (13%). EBITDA stood at ₹50.9 crore, reflecting a margin uplift of 60 basis points to 16.1%, with profit after tax rising 36.3% to ₹34.2 crore, equating to a margin of 10.8%.

**Future Outlook and Growth Drivers:** Management highlighted the operational commencement of the Jammu facility as a pivotal growth driver, anticipating revenue contributions of ₹400 crore to ₹500 crore next fiscal year from this plant. The introduction of new products and increased capabilities are set to bolster sales, alongside favorable GST-linked incentives.

**Order Book and Operational Updates:** The company is witnessing strong client interest and positive feedback for novel products from the Jammu facility. The domestic segment is expanding through enhanced distribution networks, targeting deeper market penetration, particularly in Tier 2 cities.

**Analyst Q&A Insights:** Analysts sought clarification on margins and revenue projections. Management indicated operational challenges at Sharon Bio-Medicines, attributing a revenue dip to deferred orders, but expressed confidence in recovery. They affirmed stable pricing trends in the CDMO segment, countering API price erosion impacts. The Jammu facility is expected to ramp up significantly, contributing to overall revenue growth.

**Market or Regulatory Updates:** No specific regulatory changes were noted that would alter current strategies, although there is cautious optimism regarding compliance developments under Schedule M.

**Strategic Focus Areas:** The overarching theme remains on expanding manufacturing capabilities and product differentiation, underpinning a commitment to innovation and market growth.

**Investor Insight:** Observing consistent financial growth alongside strategic operational expansions, the upward trajectory of Innova Captab’s future prospects supports a positive outlook on potential share performance, aligning towards a ‘buy’ stance based on the anticipated growth from the Jammu facility and overall strategic initiatives.